Pharmaceutical company Astellas announced several new appointments to its ethics and compliance and U.S. legal departments, effective as of April 25.
Mark Wanda will join the ethics and compliance organization in the role of executive director, anti-bribery and anti-corruption, where he will oversee global anti-bribery and anti-corruption compliance programs for Astellas. Wanda joined Astellas in 2013 as deputy general counsel, and most recently served as head of the Astellas U.S. legal regulatory team. In his new role, Wanda will report to Catherine Wertjes, senior vice president, ethics and compliance.
Nahrin Marino has been promoted to deputy general counsel and will succeed Wanda as head of Astellas U.S. legal regulatory. Marino, who will continue to serve as director of investigations, joined Astellas in 2010 as senior corporate counsel, specializing in regulatory law. She most recently served as associate general counsel, focused on regulatory, life cycle management, drug quality and manufacturing. In her new role, Marino will report to Catherine Levitt, vice president, legal.
Matt Silversten has also been promoted to deputy general counsel and is the new head of the Astellas U.S. legal department's litigation and risk management team. Silversten joined Astellas in 2011 as senior counsel litigation. He most recently served as associate general counsel, where he was responsible for litigation and dispute resolution. In his new role, Silversten will also report to Levitt.